Ishikawa H, Matsushima M, Matsui H, Honjo A, Hayashi M, Shindo T, Morifuji T, Okaybayashi M
Arzneimittelforschung. 1978;28(3):402-6.
The effect of d-3-acetoxy-cis-2,3-dihydro-5-[2-(dimethylamino)ethyl]-2-(p-methoxyphenyl)-1,5-benzothiazepine-4(5H)one hydrochloride (ditiazem hydrochloride, CRD-401) on renal hemodynamics was investigated in 18 mongrel adult dogs, and the following results were obtained. 1. Renal blood flow (RBF) was significantly increased following i.v. injection of 100 microgram/kg of CRD-401, in spite of decreased ao-tic blood pressure. Moreover the same dose of the drug elicited greater increase in RBF while the renal arteries were perfused at a constant pressure in order to prevent the decrease in systemic blood pressure from affecting RBF. These results suggest that CRD-401 has a vasodilatory action on the renal arteries. 2. The increasing rate of RBF and decreasing rate of renal vascular resistance (RVR) after injection of the drug into the renal artery at the dose level of 3 microgram/kg were found to diminish by pretreatment with hexamethonium (C6) before CRD-401. The vasodilating effect of CRD-401 on the renal arteries was therefore assumed to be more prominent in a state of renal arterial constriction. 3. RBF and RVR were increased and decreased, respectively, in proportion to the doses of CRD-401 ranging from 3 to 100 microgram/kg, the vasodilating action of CRD-401 on the renal arteries increased dose-dependently.
在18只成年杂种犬身上研究了盐酸d-3-乙酰氧基-顺式-2,3-二氢-5-[2-(二甲氨基)乙基]-2-(对甲氧基苯基)-1,5-苯并硫氮杂䓬-4(5H)酮(盐酸地尔硫䓬,CRD-401)对肾血流动力学的影响,结果如下。1.静脉注射100微克/千克的CRD-401后,尽管主动脉血压下降,但肾血流量(RBF)仍显著增加。此外,当以恒定压力灌注肾动脉以防止全身血压下降影响RBF时,相同剂量的药物引起RBF更大幅度的增加。这些结果表明CRD-401对肾动脉有血管舒张作用。2.发现在CRD-401注射前用六甲铵(C6)预处理后,以3微克/千克的剂量水平将药物注入肾动脉后,RBF的增加率和肾血管阻力(RVR)的降低率会降低。因此,推测CRD-401在肾动脉收缩状态下对肾动脉的血管舒张作用更为显著。3.随着CRD-401剂量从3微克/千克增加到100微克/千克,RBF和RVR分别相应增加和降低,CRD-401对肾动脉的血管舒张作用呈剂量依赖性增加。